Picture of Hisamitsu Pharmaceutical Co logo

4530 — Hisamitsu Pharmaceutical Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Table: Hisamitsu -2025/26 parent results

Apr 13 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Feb 28, 2026    Feb 28, 2025   Feb 28, 2027     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            103.76          102.62                                
                 (+1.1 pct)      (+6.2 pct)                              
  Operating          7.44           13.71                                
                 (-45.8 pct)     (+28.1 pct)                             
  Recurring         11.29           16.51                                
                 (-31.6 pct)     (+16.1 pct)                             
  Net                9.25           16.36                                
                 (-43.5 pct)     (+66.0 pct)                             
  EPS            129.55 yen      222.20 yen                              
  EPS Diluted    129.39 yen      221.88 yen                              
  Ann Div         60.00 yen       90.00 yen                              
  -Q2 Div         60.00 yen       45.00 yen                              
  -Q4 Div            NIL          45.00 yen                              
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T

Recent news on Hisamitsu Pharmaceutical Co

See all news